Analysis of the TCGA-KIRC cohort revealed differential COL6A2 transcript expression both in an unpaired comparison of 539 ccRCC tumors against 72 normal tissues and in a paired analysis of 72 matched tumor and adjacent normal specimens. This evidence concerns the gene COL6A2 and nonpapillary renal cell carcinoma.